Dr Reddy’s Aghanian Highlights European Opportunities
Discusses European Generics Pricing, Biosimilars Strategy And Potential For M&A
Dr Reddy’s sees plenty of opportunity in Europe, including for the firm’s burgeoning biosimilars business. However at the same time, current European pricing policies risk exacerbating shortages and are discouraging investment, the firm’s CEO of European operations for global generics, Patrick Aghanian, tells Generics Bulletin in an exclusive interview.
